From FDA Approves First Drug for Exelixis of South San Francisco:

Exelixis Logo
Exelixis Logo

Exelixis (NASDAQ: EXEL) is a South San Francisco biotechnology company developing drugs for thyroid cancer, prostate cancer, and other conditions.